Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Healthy people in healthy premises: the Finnish Indoor Air and Health Programme 2018-2028.

Lampi J, Hyvärinen A, Erhola M, Haahtela T, Haukipuro K, Haverinen-Shaughnessy U, Jalkanen K, Karvala K, Lappalainen S, Reijula K, Rämö H, Sainio M, Salmela A, Salminen M, Vasankari T, Pekkanen J.

Clin Transl Allergy. 2020 Jan 17;10:4. doi: 10.1186/s13601-020-0308-1. eCollection 2020.

2.

From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.

Bousquet J, Anto JM, Bachert C, Bosnic-Anticevich S, Erhola M, Haahtela T, Hellings PW, Kuna P, Pfaar O, Samolinski B, Schünemann HJ, Sheikh A, Wallace D; ARIA study group.

Eur Respir J. 2019 Dec 4;54(6). pii: 1901023. doi: 10.1183/13993003.01023-2019. Print 2019 Dec. No abstract available.

PMID:
31801821
3.

Helsinki by nature: The Nature Step to Respiratory Health.

Haahtela T, von Hertzen L, Anto JM, Bai C, Baigenzhin A, Bateman ED, Behera D, Bennoor K, Camargos P, Chavannes N, de Sousa JC, Cruz A, Do Céu Teixeira M, Erhola M, Furman E, Gemicioğlu B, Gonzalez Diaz S, Hellings PW, Jousilahti P, Khaltaev N, Kolek V, Kuna P, La Grutta S, Lan LTT, Maglakelidze T, Masjedi MR, Mihaltan F, Mohammad Y, Nunes E, Nyberg A, Quel J, Rosado-Pinto J, Sagara H, Samolinski B, Schraufnagel D, Sooronbaev T, Tag Eldin M, To T, Valiulis A, Varghese C, Vasankari T, Viegi G, Winders T, Yañez A, Yorgancioğlu A, Yusuf O, Bousquet J, Billo NE.

Clin Transl Allergy. 2019 Oct 30;9:57. doi: 10.1186/s13601-019-0295-2. eCollection 2019. Review.

4.

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T.

J Thorac Dis. 2019 Sep;11(9):4072-4084. doi: 10.21037/jtd.2019.09.38. Review. No abstract available.

5.

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.

Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, Klimek L, Pfaar O, Wallace D, Ansotegui I, Agache I, Bedbrook A, Bergmann KC, Bewick M, Bonniaud P, Bosnic-Anticevich S, Bossé I, Bouchard J, Boulet LP, Brozek J, Brusselle G, Calderon MA, Canonica WG, Caraballo L, Cardona V, Casale T, Cecchi L, Chu DK, Costa EM, Cruz AA, Czarlewski W, D'Amato G, Devillier P, Dykewicz M, Ebisawa M, Fauquert JL, Fokkens WJ, Fonseca JA, Fontaine JF, Gemicioglu B, van Wijk RG, Haahtela T, Halken S, Ierodiakonou D, Iinuma T, Ivancevich JC, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kleine Tebbe J, Kowalski ML, Kuna P, Kvedariene V, La Grutta S, Larenas-Linnemann D, Lau S, Laune D, Le L, Lieberman P, Lodrup Carlsen KC, Lourenço O, Marien G, Carreiro-Martins P, Melén E, Menditto E, Neffen H, Mercier G, Mosgues R, Mullol J, Muraro A, Namazova L, Novellino E, O'Hehir R, Okamoto Y, Ohta K, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Price D, Roberts G, Roche N, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding GK, Shamji MH, Sheikh A, Bom AT, Toppila-Salmi S, Tsiligianni I, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Walker S, Waserman S, Yorgancioglu A, Zuberbier T; Allergic Rhinitis and Its Impact on Asthma Working Group.

J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3. doi: 10.1016/j.jaci.2019.06.049. Epub 2019 Oct 15. Review.

PMID:
31627910
6.

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T.

J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64. No abstract available.

7.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Bousquet JJ, Schünemann HJ, Togias A, Erhola M, Hellings PW, Zuberbier T, Agache I, Ansotegui IJ, Anto JM, Bachert C, Becker S, Bedolla-Barajas M, Bewick M, Bosnic-Anticevich S, Bosse I, Boulet LP, Bourrez JM, Brusselle G, Chavannes N, Costa E, Cruz AA, Czarlewski W, Fokkens WJ, Fonseca JA, Gaga M, Haahtela T, Illario M, Klimek L, Kuna P, Kvedariene V, Le LTT, Larenas-Linnemann D, Laune D, Lourenço OM, Menditto E, Mullol J, Okamoto Y, Papadopoulos N, Pham-Thi N, Picard R, Pinnock H, Roche N, Roller-Wirnsberger RE, Rolland C, Samolinski B, Sheikh A, Toppila-Salmi S, Tsiligianni I, Valiulis A, Valovirta E, Vasankari T, Ventura MT, Walker S, Williams S, Akdis CA, Annesi-Maesano I, Arnavielhe S, Basagana X, Bateman E, Bedbrook A, Bennoor KS, Benveniste S, Bergmann KC, Bialek S, Billo N, Bindslev-Jensen C, Bjermer L, Blain H, Bonini M, Bonniaud P, Bouchard J, Briedis V, Brightling CE, Brozek J, Buhl R, Buonaiuto R, Canonica GW, Cardona V, Carriazo AM, Carr W, Cartier C, Casale T, Cecchi L, Cepeda Sarabia AM, Chkhartishvili E, Chu DK, Cingi C, Colgan E, de Sousa JC, Courbis AL, Custovic A, Cvetkosvki B, D'Amato G, da Silva J, Dantas C, Dokic D, Dauvilliers Y, Dedeu A, De Feo G, Devillier P, Di Capua S, Dykewickz M, Dubakiene R, Ebisawa M, El-Gamal Y, Eller E, Emuzyte R, Farrell J, Fink-Wagner A, Fiocchi A, Fontaine JF, Gemicioğlu B, Schmid-Grendelmeir P, Gamkrelidze A, Garcia-Aymerich J, Gomez M, González Diaz S, Gotua M, Guldemond NA, Guzmán MA, Hajjam J, O'B Hourihane J, Humbert M, Iaccarino G, Ierodiakonou D, Illario M, Ivancevich JC, Joos G, Jung KS, Jutel M, Kaidashev I, Kalayci O, Kardas P, Keil T, Khaitov M, Khaltaev N, Kleine-Tebbe J, Kowalski ML, Kritikos V, Kull I, Leonardini L, Lieberman P, Lipworth B, Lodrup Carlsen KC, Loureiro CC, Louis R, Mair A, Marien G, Mahboub B, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu-Dupas E, Matricardi PM, Melén E, Melo-Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica-Martinez MD, Mohammad Y, Montefort S, Monti R, Morais-Almeida M, Mösges R, Münter L, Muraro A, Murray R, Naclerio R, Napoli L, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Novellino E, Nyembue D, O'Hehir R, Ohta K, Okubo K, Onorato G, Ouedraogo S, Pali-Schöll I, Palkonen S, Panzner P, Park HS, Pépin JL, Pereira AM, Pfaar O, Paulino E, Phillips J, Picard R, Plavec D, Popov TA, Portejoie F, Price D, Prokopakis EP, Pugin B, Raciborski F, Rajabian-Söderlund R, Reitsma S, Rodo X, Romano A, Rosario N, Rottem M, Ryan D, Salimäki J, Sanchez-Borges MM, Sisul JC, Solé D, Somekh D, Sooronbaev T, Sova M, Spranger O, Stellato C, Stelmach R, Suppli Ulrik C, Thibaudon M, To T, Todo-Bom A, Tomazic PV, Valero AA, Valenta R, Valentin-Rostan M, van der Kleij R, Vandenplas O, Vezzani G, Viart F, Viegi G, Wallace D, Wagenmann M, Wang Y, Waserman S, Wickman M, Williams DM, Wong G, Wroczynski P, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zeng S, Zernotti M, Zhang L, Zhong NS, Zidarn M; ARIA Study Group; MASK Study Group.

Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Review.

8.

Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

Bousquet J, Ansotegui IJ, Anto JM, Arnavielhe S, Bachert C, Basagaña X, Bédard A, Bedbrook A, Bonini M, Bosnic-Anticevich S, Braido F, Cardona V, Czarlewski W, Cruz AA, Demoly P, De Vries G, Dramburg S, Mathieu-Dupas E, Erhola M, Fokkens WJ, Fonseca JA, Haahtela T, Hellings PW, Illario M, Ivancevich JC, Jormanainen V, Klimek L, Kuna P, Kvedariene V, Laune D, Larenas-Linnemann D, Lourenço O, Onorato GL, Matricardi PM, Melén E, Mullol J, Papadopoulos NG, Pfaar O, Pham-Thi N, Sheikh A, Tan R, To T, Tomazic PV, Toppila-Salmi S, Tripodi S, Wallace D, Valiulis A, van Eerd M, Ventura MT, Yorgancioglu A, Zuberbier T.

J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2511-2523. doi: 10.1016/j.jaip.2019.07.044. Epub 2019 Aug 21.

PMID:
31445223
9.

25 years of respiratory health in Finland.

Erhola M, Vasankari T, Jormanainen V, Toppila-Salmi S, Herrala J, Haahtela T.

Lancet Respir Med. 2019 May;7(5):e16. doi: 10.1016/S2213-2600(19)30122-5. No abstract available.

PMID:
31046969
10.

Asthma Programme in Finland: Did the use of secondary care resources become more rational?

Tuomisto LE, Erhola M, Luukkaala T, Puolijoki H, Nieminen MM, Kaila M.

Respir Med. 2010 Jul;104(7):957-65. doi: 10.1016/j.rmed.2010.01.018. Epub 2010 Mar 5.

11.

Authors' reply.

Tuomisto LE, Järvinen V, Laitinen J, Erhola M, Kaila M, Brander PE.

Prim Care Respir J. 2009 Sep;18(3):232. doi: 10.4104/pcrj.2009.00033. Epub 2009 Aug 6. No abstract available.

12.

Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer.

Crohns M, Liippo K, Erhola M, Kankaanranta H, Moilanen E, Alho H, Kellokumpu-Lehtinen P.

Clin Biochem. 2009 Aug;42(12):1236-45. doi: 10.1016/j.clinbiochem.2009.05.003. Epub 2009 May 13.

PMID:
19445914
13.

Development process of the Practical Approach to Lung Health in Kyrgyzstan.

Erhola ML, Brimkulov N, Chubakov T, Niemi L, Bergman V, Lahdensuo A, Pio A, Ottmani SE.

Int J Tuberc Lung Dis. 2009 Apr;13(4):540-4.

PMID:
19335963
14.

Feasibility test results of the Practical Approach to Lung Health in Bishkek, Kyrgyzstan.

Brimkulov N, Ottmani SE, Pio A, Chubakov T, Sultanova A, Davletalieva N, Kalieva A, Rittman J, Erhola M, Cholurova R, Blanc L.

Int J Tuberc Lung Dis. 2009 Apr;13(4):533-9.

PMID:
19335962
15.

Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patients.

Crohns M, Saarelainen S, Erhola M, Alho H, Kellokumpu-Lehtinen P.

Clin Biochem. 2009 Jul;42(10-11):1082-90. doi: 10.1016/j.clinbiochem.2009.02.022. Epub 2009 Mar 6.

PMID:
19272366
16.

Asthma Programme in Finland: the quality of primary care spirometry is good.

Tuomisto L, Jarvinen V, Laitinen J, Erhola M, Kaila M, Brander P.

Prim Care Respir J. 2008 Dec;17(4):226-31. doi: 10.3132/pcrj.2008.00053. Erratum in: Prim Care Respir J. 2009 Sep;18(3):184. Erratum in: Prim Care Respir J. 2009 Sep;18(3):184.

17.

The Finnish national asthma programme: communication in asthma care--quality assessment of asthma referral letters.

Tuomisto LE, Erhola M, Kaila M, Brander PE, Kauppinen R, Puolijoki H, Kekki P.

J Eval Clin Pract. 2007 Feb;13(1):50-4. Erratum in: J Eval Clin Pract. 2009 Apr;15(2):408. Marina, Erhola [corrected to Erhola, Marina]; Minna, Kaila [corrected to Kaila, Minna]; Ritva, Kauppinen [corrected to Kauppinen, Ritva]; Hannu, Puolijoki [corrected to Puolijoki, Hannu]; Pertti, Kekki [corrected to Kekki, Pertti].

PMID:
17286723
18.

Asthma programme in Finland: comparison of adult asthma referral letters in 1994 and 2001.

Tuomisto LE, Kaila M, Erhola M.

Respir Med. 2007 Mar;101(3):595-600. Epub 2006 Aug 4.

19.

A 10 year asthma programme in Finland: major change for the better.

Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA.

Thorax. 2006 Aug;61(8):663-70.

20.

Asthma Programme in Finland: high consensus between general practitioners and pulmonologists on the contents of an asthma referral letter.

Tuomisto L, Erhola M, Kaila M, Brander PE, Puolijoki H, Kauppinen R, Koskela K.

Prim Care Respir J. 2004 Dec;13(4):205-10.

21.

[Current Care Guidelines, foundation for regional and coordinated management programs].

Nuutinen L, Nuutinen M, Erhola M.

Duodecim. 2004;120(24):2955-62. Review. Finnish. No abstract available.

PMID:
15700596
22.

The asthma programme of Finland: an evaluation survey in primary health care.

Erhola M, Mäkinen R, Koskela K, Bergman V, Klaukka T, Mäkelä M, Tirkkonen L, Kaila M.

Int J Tuberc Lung Dis. 2003 Jun;7(6):592-8.

PMID:
12797704
23.

Assay of antioxidant capacity of human plasma and CSF in aging and disease.

Alho H, Leinonen JS, Erhola M, Lönnrot K, Aejmelaeus R.

Restor Neurol Neurosci. 1998 Jun;12(2-3):159-65.

PMID:
12671311
24.

Asthma programme in Finland: a community problem needs community solutions.

Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA; Working Group of the Asthma Programme in Finland 1994-2004.

Thorax. 2001 Oct;56(10):806-14. No abstract available.

25.

Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study.

Erhola M, Nieminen MM, Ojala A, Metsä-Ketelä T, Kellokumpu-Lehtinen P, Alho H.

J Exp Clin Cancer Res. 1998 Sep;17(3):325-30.

PMID:
9894770
26.

Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients.

Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, Huusari H, Alanko K, Metsä-Ketelä T, Alho H.

J Exp Clin Cancer Res. 1998 Jun;17(2):219-25.

PMID:
9700584
27.

Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment.

Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P.

FEBS Lett. 1997 Jun 9;409(2):287-91.

28.

Plasma peroxyl radical trapping capacity in lung cancer patients: a case-control study.

Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, Metsä-Ketelä T, Poussa T, Alho H.

Free Radic Res. 1997 May;26(5):439-47.

PMID:
9179589
29.

Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients.

Erhola M, Kellokumpu-Lehtinen P, Metsä-Ketelä T, Alanko K, Nieminen MM.

Free Radic Biol Med. 1996;21(3):383-90.

PMID:
8855450

Supplemental Content

Loading ...
Support Center